Download PDF

Mastering Cardiology · Cheat sheet

ACLS decision points

Draft — pending owner review

Decision points

  1. Rhythm check: is it shockable?
    Cardiac arrest: VF, pulseless VT, asystole and PEA: Yes: VF or pulseless VT No: asystole or PEA
  2. Is the bradyarrhythmia causing any of these? (Hypotension; Acutely altered mental status; Signs of shock; Ischemic chest discomfort; Acute heart failure)
    Bradycardia with a pulse: No Yes
  3. Is the tachyarrhythmia causing any of these? (Hypotension; Acutely altered mental status; Signs of shock; Ischemic chest discomfort; Acute heart failure)
    Tachycardia with a pulse: Yes: unstable No: stable
  4. Is the QRS wide (≥ 120 ms)?
    Tachycardia with a pulse: Wide Narrow
  5. Is there an organized QRS to synchronize to?
    Electrical therapy: cardioversion, defibrillation and pacing: No: VF, pulseless VT, polymorphic VT Yes: unstable SVT, AF, flutter, monomorphic VT with a pulse
  6. Symptomatic bradycardia not responding to atropine?
    Electrical therapy: cardioversion, defibrillation and pacing: Yes No
  7. 12-lead ECG: STEMI, cardiogenic shock or a likely cardiac cause?
    Post–cardiac arrest care: STEMI, shock or high suspicion No
  8. Is the patient following commands (off sedation)?
    Post–cardiac arrest care: No, or cannot assess Yes
  9. What does the 12-lead show?
    Acute coronary syndromes: ST elevation (STEMI) or an occlusion equivalent ST depression or dynamic T-wave inversion Normal or nondiagnostic
  10. Can primary PCI happen within 120 minutes of first medical contact?
    Acute coronary syndromes: Yes No, and onset within 12 hours
  11. Does imaging show hemorrhage?
    Suspected stroke: Yes: hemorrhage No hemorrhage
  12. Within 4.5 hours of last known well, and eligible?
    Suspected stroke: Yes No, or ineligible
  13. Large vessel occlusion on CT angiography?
    Suspected stroke: Yes No
  14. Is the person breathing normally?
    Opioid-associated emergency: Yes No
  15. Is there a definite pulse (check for no more than 10 seconds)?
    Opioid-associated emergency: Yes: respiratory arrest No: cardiac arrest
  16. Breathing restored?
    Opioid-associated emergency: Yes No
  17. ROSC within the first few minutes?
    Cardiac arrest in pregnancy: Yes No
  18. PEA or asystole: which cause fits the clues?
    PEA: the H's and T's: Hypovolemia Hypoxia Hydrogen ion (acidosis) Hypo- or hyperkalemia Hypothermia Tension pneumothorax Tamponade (cardiac) Toxins Thrombosis (pulmonary) Thrombosis (coronary) I have been through the list
  19. Rhythm check: is it shockable?
    Pediatric cardiac arrest (PALS): Shockable: VF or pulseless VT Not shockable: asystole or PEA
  20. After 2 minutes: rhythm check
    Pediatric cardiac arrest (PALS): Still shockable ROSC Asystole or PEA
  21. Rhythm check
    Pediatric cardiac arrest (PALS): Still shockable ROSC Asystole or PEA
  22. After 2 minutes: rhythm check
    Pediatric cardiac arrest (PALS): Now shockable Still asystole or PEA ROSC
  23. Cardiopulmonary compromise? (hypotension, acutely altered mental status, signs of shock)
    Pediatric bradycardia with a pulse (PALS): No Yes
  24. Despite oxygenation and ventilation: heart rate below 60/min with poor perfusion?
    Pediatric bradycardia with a pulse (PALS): Yes No: rate above 60
  25. Bradycardia persists?
    Pediatric bradycardia with a pulse (PALS): Yes No: rate and perfusion improved
  26. Is the QRS narrow (0.09 s or less) or wide (more than 0.09 s)?
    Pediatric tachycardia with a pulse (PALS): Narrow Wide
  27. Probable sinus tachycardia or SVT?
    Pediatric tachycardia with a pulse (PALS): Probable sinus tachycardia Probable SVT
  28. Cardiopulmonary compromise?
    Pediatric tachycardia with a pulse (PALS): No Yes
  29. Possible VT: cardiopulmonary compromise?
    Pediatric tachycardia with a pulse (PALS): Yes No
  30. Reassess after each bolus
    Pediatric septic shock (PALS): Improving, no overload Overload signs: crackles, enlarging liver Still in shock after 40–60 mL/kg
  31. Still in shock on vasoactive infusions?
    Pediatric septic shock (PALS): Yes No

Reversible causes

H's
Hypovolemia, hypoxia, hydrogen ion (acidosis), hypo-/hyperkalemia, hypothermia
T's
Tension pneumothorax, tamponade, toxins, thrombosis (pulmonary), thrombosis (coronary)

Energies and doses

Verify against current local protocol. The full 2025 guideline text could not be opened when this page was drafted; the 2025 changes listed were confirmed from summaries of AHA's published 2025 algorithms and highlights. Drug doses are the 2020 algorithm doses, which those 2025 algorithms keep.

Defibrillation, biphasicManufacturer recommendation (for example, initial dose of 120–200 J); if unknown, use the maximum available. Second and later doses should be equivalent; higher doses may be considered.AHA 2020 adult algorithm
Defibrillation, monophasic360 JAHA 2020 adult algorithm
Epinephrine IV/IO1 mg every 3–5 minutesAHA 2020 adult algorithm
Amiodarone IV/IOFirst dose 300 mg bolus; second dose 150 mgAHA 2020 adult algorithm
Lidocaine IV/IO (alternative to amiodarone)First dose 1–1.5 mg/kg; second dose 0.5–0.75 mg/kgAHA 2020 adult algorithm
Atropine IVFirst dose 1 mg bolus; repeat every 3–5 minutes; maximum 3 mgAHA 2020 adult algorithm
Dopamine IV infusion5–20 mcg/kg per minute; titrate to patient response; taper slowlyAHA 2020 adult algorithm
Epinephrine IV infusion2–10 mcg per minute; titrate to patient responseAHA 2020 adult algorithm
Synchronized cardioversionRefer to your specific device's recommended energy level to maximize first-shock success.AHA 2020 adult algorithm
Synchronized cardioversion of AF (2025 change)Initial energy of at least 200 J with a biphasic defibrillatorAHA 2025 Guidelines, Part 9: Adult Advanced Life Support (as reported in the 2025 highlights)
Adenosine IVFirst dose 6 mg rapid IV push, followed by a normal saline flush; second dose 12 mg if requiredAHA 2020 adult algorithm
Procainamide IV (stable wide-QRS)20–50 mg/min until the arrhythmia is suppressed, hypotension ensues, QRS duration increases > 50% or a maximum of 17 mg/kg is given; maintenance 1–4 mg/min; avoid if prolonged QT or heart failureAHA 2020 adult algorithm
Amiodarone IV (stable wide-QRS)First dose 150 mg over 10 minutes; repeat as needed if VT recurs; follow with a maintenance infusion of 1 mg/min for the first 6 hoursAHA 2020 adult algorithm
Sotalol IV (stable wide-QRS)100 mg (1.5 mg/kg) over 5 minutes; avoid if prolonged QT. No longer listed in the 2025 algorithm.AHA 2020 adult algorithm; removed from the AHA 2025 algorithm
OxygenTitrate FiO₂ to SpO₂ 90–98%AHA 2025 post-cardiac arrest care algorithm
VentilationPaCO₂ 35–45 mm HgAHA 2025 post-cardiac arrest care algorithm
Blood pressureMAP 65 mm Hg or more (fluids, norepinephrine or epinephrine infusion)AHA 2025 post-cardiac arrest care algorithm
Temperature controlGoal 32–37.5 °C for at least 36 hours if not following commands; prevent feverAHA 2025 Guidelines, Part 11 (duration as reported in summaries; confirm)
Aspirin162–325 mg chewed (non-enteric-coated)ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS teaching
Nitroglycerin0.4 mg sublingual every 5 minutes, up to 3 doses, if systolic BP ≥ 90ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS teaching
OxygenOnly if SpO₂ < 90%ACC/AHA 2025 acute coronary syndromes guideline
Alteplase0.9 mg/kg (max 90 mg): 10% as a bolus over 1 minute, the rest over 60 minutesAHA/ASA stroke guidelines (2019, 2026) as taught in AHA 2020 ACLS
Tenecteplase0.25 mg/kg (max 25 mg) single bolusAHA/ASA 2026 stroke guideline (as reported); not in AHA 2020 ACLS
Blood pressure before thrombolysisBelow 185/110 mm Hg; then at or below 180/105 for 24 hoursAHA/ASA stroke guidelines as taught in AHA 2020 ACLS
Naloxone intranasal4 mg, repeat every 2–3 minutesAHA 2020 opioid-associated emergency algorithms; naloxone endorsed in the AHA 2025 guidelines
Naloxone IM/IV0.4 mg, titrated, repeat every 2–3 minutesAHA 2020 opioid-associated emergency algorithms; naloxone endorsed in the AHA 2025 guidelines
Defibrillation and drugsStandard adult energies and dosesAHA 2025 cardiac arrest in pregnancy algorithm
Resuscitative hysterotomyIf no ROSC: aim for delivery about 5 minutes after the arrestAHA 2025 cardiac arrest in pregnancy algorithm
Calcium chlorideFor hyperkalemia, calcium-channel blocker toxicity or hypermagnesemia; not routineAHA 2025 Guidelines, Part 9 (specific causes only)
Sodium bicarbonate1 mEq/kg for hyperkalemia or sodium-channel blocker toxicity; not routineAHA 2025 Guidelines, Part 9 (specific causes only)
Defibrillation2 J/kg, then 4 J/kg, then ≥4 J/kg (max 10 J/kg or the adult dose)AHA 2025 PALS cardiac arrest algorithm
Epinephrine IV/IO0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL), max 1 mg, every 3–5 minutesAHA 2020 PALS algorithm; AHA 2025 PALS algorithm
Amiodarone IV/IO5 mg/kg bolus, may repeat up to 3 total dosesAHA 2020 PALS algorithm; AHA 2025 PALS algorithm
Lidocaine IV/IO1 mg/kg loading doseAHA 2020 PALS algorithm; AHA 2025 PALS algorithm
Epinephrine IV/IO0.01 mg/kg every 3–5 minutesAHA 2020 PALS bradycardia algorithm
Atropine IV/IO0.02 mg/kg, may repeat once; max single dose 0.5 mgAHA 2020 PALS bradycardia algorithm (owner to confirm the 2025 wording)
Adenosine IV/IO0.1 mg/kg rapid push (max 6 mg); second dose 0.2 mg/kg (max 12 mg)AHA 2020 PALS tachycardia algorithm
Synchronized cardioversion0.5–1 J/kg; if not effective, 2 J/kgAHA 2020 PALS tachycardia algorithm
Amiodarone IV/IO (wide QRS, with a pulse)5 mg/kg over 20–60 minutesAHA 2020 PALS tachycardia algorithm
Procainamide IV/IO (wide QRS, with a pulse)15 mg/kg over 30–60 minutesAHA 2020 PALS tachycardia algorithm
Fluid bolus10–20 mL/kg isotonic crystalloid; 5–10 mL/kg with cardiac dysfunctionAHA 2020 PALS septic shock guidance
Epinephrine or norepinephrine infusionTitrated to perfusion (epinephrine 0.1–1, norepinephrine 0.05–2 mcg/kg/min)AHA 2020 PALS septic shock guidance (ranges to confirm)

Follows the AHA 2020 Guidelines for CPR and ECC, adult algorithms (Part 3: Adult Basic and Advanced Life Support, Circulation 2020;142(suppl 2):S366–S468), with 2025 changes where confirmed.